These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33490983)

  • 61. Bystander CD8
    Simoni Y; Becht E; Fehlings M; Loh CY; Koo SL; Teng KWW; Yeong JPS; Nahar R; Zhang T; Kared H; Duan K; Ang N; Poidinger M; Lee YY; Larbi A; Khng AJ; Tan E; Fu C; Mathew R; Teo M; Lim WT; Toh CK; Ong BH; Koh T; Hillmer AM; Takano A; Lim TKH; Tan EH; Zhai W; Tan DSW; Tan IB; Newell EW
    Nature; 2018 May; 557(7706):575-579. PubMed ID: 29769722
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer.
    Jin R; Liu C; Zheng S; Wang X; Feng X; Li H; Sun N; He J
    Cancer Biol Med; 2020 Aug; 17(3):768-781. PubMed ID: 32944405
    [No Abstract]   [Full Text] [Related]  

  • 63. Intrinsic β-catenin signaling suppresses CD8
    Xue J; Yu X; Xue L; Ge X; Zhao W; Peng W
    Biomed Pharmacother; 2019 Jul; 115():108921. PubMed ID: 31078045
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Targeting the ERβ/HER Oncogenic Network in
    Almotlak AA; Farooqui M; Soloff AC; Siegfried JM; Stabile LP
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008514
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune Response.
    Reiser J; Banerjee A
    J Immunol Res; 2016; 2016():8941260. PubMed ID: 27314056
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Protocol for the isolation of CD8+ tumor-infiltrating lymphocytes from human tumors and their characterization by single-cell immune profiling and multiome.
    Anadon CM; Zhang C; Wang X; Cen L; Conejo-Garcia JR; Yu X
    STAR Protoc; 2022 Sep; 3(3):101649. PubMed ID: 36065294
    [TBL] [Abstract][Full Text] [Related]  

  • 67. CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner.
    Zhang QF; Li J; Jiang K; Wang R; Ge JL; Yang H; Liu SJ; Jia LT; Wang L; Chen BL
    Theranostics; 2020; 10(23):10619-10633. PubMed ID: 32929370
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Accumulation of tissue-resident natural killer cells, innate lymphoid cells, and CD8
    Brownlie D; von Kries A; Valenzano G; Wild N; Yilmaz E; Säfholm J; Al-Ameri M; Alici E; Ljunggren HG; Schliemann I; Aricak O; Haglund de Flon F; Michaëlsson J; Marquardt N
    Oncoimmunology; 2023; 12(1):2233402. PubMed ID: 37448786
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Tissue-Resident Memory T Cells in Cancer Immunosurveillance.
    Park SL; Gebhardt T; Mackay LK
    Trends Immunol; 2019 Aug; 40(8):735-747. PubMed ID: 31255505
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Expression of B7-H2 on CD8
    Cao Y; Cao T; Zhao W; He F; Lu Y; Zhang G; Hu H; Wang Z
    Int Immunopharmacol; 2018 Mar; 56():128-134. PubMed ID: 29414642
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Resident memory CD8+ T cells within cancer islands mediate survival in breast cancer patients.
    Egelston CA; Avalos C; Tu TY; Rosario A; Wang R; Solomon S; Srinivasan G; Nelson MS; Huang Y; Lim MH; Simons DL; He TF; Yim JH; Kruper L; Mortimer J; Yost S; Guo W; Ruel C; Frankel PH; Yuan Y; Lee PP
    JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31465302
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Discipline in Stages: Regulating CD8
    Mora-Buch R; Bromley SK
    Front Immunol; 2020; 11():624199. PubMed ID: 33815352
    [TBL] [Abstract][Full Text] [Related]  

  • 73. T-cell exhaustion interrelates with immune cytolytic activity to shape the inflamed tumor microenvironment.
    Cai MC; Zhao X; Cao M; Ma P; Chen M; Wu J; Jia C; He C; Fu Y; Tan L; Xue X; Yu Z; Zhuang G
    J Pathol; 2020 Jun; 251(2):147-159. PubMed ID: 32222046
    [TBL] [Abstract][Full Text] [Related]  

  • 74. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
    Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W
    Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402
    [TBL] [Abstract][Full Text] [Related]  

  • 75. CD8
    Panigrahi S; Bazdar DA; Albakri M; Ferrari B; Antonelli CJ; Freeman ML; Dubyak G; Zender C; Sieg SF
    Eur J Immunol; 2020 Dec; 50(12):2055-2066. PubMed ID: 32548862
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prognostic Relevance of the Relative Presence of CD4, CD8 and CD20 Expressing Tumor Infiltrating Lymphocytes in Operable Non-small Cell Lung Cancer Patients.
    Giatromanolaki A; Anestopoulos I; Panayiotidis MI; Mitrakas A; Pappa A; Koukourakis MI
    Anticancer Res; 2021 Aug; 41(8):3989-3995. PubMed ID: 34281863
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The positive prognostic effect of stromal CD8+ tumor-infiltrating T cells is restrained by the expression of HLA-E in non-small cell lung carcinoma.
    Talebian Yazdi M; van Riet S; van Schadewijk A; Fiocco M; van Hall T; Taube C; Hiemstra PS; van der Burg SH
    Oncotarget; 2016 Jan; 7(3):3477-88. PubMed ID: 26658106
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Integrin-α
    Malenica I; Adam J; Corgnac S; Mezquita L; Auclin E; Damei I; Grynszpan L; Gros G; de Montpréville V; Planchard D; Théret N; Besse B; Mami-Chouaib F
    Nat Commun; 2021 Sep; 12(1):5209. PubMed ID: 34471106
    [TBL] [Abstract][Full Text] [Related]  

  • 79. CX3CR1-CD8+ T cells are critical in antitumor efficacy but functionally suppressed in the tumor microenvironment.
    Yamauchi T; Hoki T; Oba T; Saito H; Attwood K; Sabel MS; Chang AE; Odunsi K; Ito F
    JCI Insight; 2020 Apr; 5(8):. PubMed ID: 32255766
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Characterization of the tumor immune-microenvironment of lung adenocarcinoma associated with usual interstitial pneumonia.
    Ueda T; Aokage K; Mimaki S; Tane K; Miyoshi T; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Kusumoto M; Suzuki K; Tsuchihara K; Nishikawa H; Goto K; Tsuboi M; Ishii G
    Lung Cancer; 2018 Dec; 126():162-169. PubMed ID: 30527182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.